234 A phase 1, open-label, dose-finding study to assess the safety and tolerability of U3 1287 (AMG 888), a human monoclonal antibody targeting HER3 in patients with advanced solid tumors

✍ Scribed by P. LoRusso; V. Keedy; L. Yee; M. Oliveira; N. Rizvi; J. Berlin; X. Jin; T. Hettmann; C. Copigneaux; D. Beaupre

• Book ID: 119602915
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 53 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)71939-x